Go Pro

Bard Associates Inc. Acquires New Position in inTEST Co. $INTT

inTEST logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Bard Associates acquired 210,598 shares of inTEST in the second quarter, worth approximately $3.83 million and representing about 1.68% of the company. Other institutions, including BlackRock, also initiated positions, while institutional investors collectively own 63.18% of inTEST.
  • Analyst sentiment remains positive overall: Northland Securities upgraded inTEST to “outperform” with a $15 target, while the consensus rating is “Moderate Buy” with a $17 price target.
  • inTEST shares opened at $11.68 after a 4% decline, below their 50-day and 200-day moving averages of $14.89 and $14.70, respectively. The company has a market capitalization of roughly $149.8 million and a one-year trading range of $6.85 to $20.00.
  • Five stocks we like better than inTEST.

Bard Associates Inc. bought a new position in inTEST Co. (NYSE:INTT - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 210,598 shares of the company's stock, valued at approximately $3,827,000. Bard Associates Inc. owned approximately 1.68% of inTEST at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of inTEST during the 2nd quarter valued at $17,008,000. Deutsche Bank AG bought a new position in shares of inTEST in the second quarter worth about $210,000. Bank of New York Mellon Corp bought a new stake in inTEST during the 2nd quarter valued at approximately $1,404,000. State of Wyoming purchased a new position in inTEST in the 2nd quarter worth approximately $71,000. Finally, GSA Capital Partners LLP bought a new position in shares of inTEST during the second quarter worth $367,000. Hedge funds and other institutional investors own 63.18% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on INTT shares. Northland Securities raised shares of inTEST from a "market perform" rating to an "outperform" rating and set a $15.00 target price for the company in a report on Monday, August 3rd. Zacks Research lowered shares of inTEST from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $17.00.

View Our Latest Analysis on INTT

inTEST Trading Down 4.0%

NYSE:INTT opened at $11.68 on Friday. inTEST Co. has a one year low of $6.85 and a one year high of $20.00. The firm has a 50-day simple moving average of $14.89 and a 200-day simple moving average of $14.70. The firm has a market cap of $149.81 million, a P/E ratio of 50.78 and a beta of 1.52. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26.

inTEST Company Profile

(Free Report)

inTEST Corporation NYSE: INTT is a developer and manufacturer of precision instrumentation and test solutions designed for the semiconductor, microelectronics and related manufacturing industries. The company's offerings focus on thermal management and instrument interface technologies that support the environmental conditioning and electrical performance evaluation of devices under test. These solutions include temperature controllers and cyclers, thermal subsystems, load boards, connectors and custom test interfaces engineered to accelerate reliability testing, product qualification and high-volume production measurement.

Serving customers across North America, Europe and Asia, inTEST supports semiconductor fabs, assembly and packaging facilities, research laboratories and OEM equipment builders.

Featured Stories

Institutional Ownership by Quarter for inTEST (NYSE:INTT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines